PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH 4'-EPI-DOXORUBICIN IN NASOPHARYNGEAL CARCINOMA PATIENTS

被引：35

作者：

HU, OYP ^{[1
]}

CHANG, SP ^{[1
]}

JAME, JM ^{[1
]}

CHEN, KY ^{[1
]}

机构：

[1] VET GEN HOSP,CTR CANC THERAPY,TAIPEI,TAIWAN

来源：

关键词：

D O I：

10.1007/BF00304769

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：332 / 337

页数：6

共 26 条

[1]

ARCAMONE F, 1975, CANCER CHEMOTH REP 3, V6, P123

[2]

BONFANTE V, 1979, CANCER TREAT REP, V63, P915

[3]

BROGGINI M, 1980, CANCER TREAT REP, V64, P897

[4]

CAMAGGI CM, 1982, CANCER TREAT REP, V66, P1819

[5]

CAMPORA E, 1984, CANCER TREAT REP, V68, P1285

CERSOSIMO, RJ ;

HONG, WK .

[7]

CHEN KY, 1984, CANCER REGISTRY BIEN

[8]

DIMARCO A, 1976, CANCER RES, V36, P1962

EKSBORG, S ;

STENDAHL, U ;

LONROTH, U .

[10]

GIBALDI M, 1982, PHARMACOKINETICS